Business Wire

Orthofix M6-C Artificial Cervical Disc IDE Study Three- and Four-Year Data to be Presented at ISASS

Data for the patients implanted with the M6-C disc in this pivotal study show retention of statistically significant benefits in disability and neck, shoulder and arm pain scores at three and four ...
Business Wire

Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years

“Additionally, M6-C patients in the study had a low rate of revision surgery compared to the ACDF cohort. Patients in the study will be monitored out to 10 years post-op as we continue to compile the ...
Healio

Prodisc C may be safe, effective at 24 months for symptomatic cervical disc disease

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Early composite clinical success showed similar outcomes ...
Nasdaq

Disc Medicine presents clinical, translational data acroos portfolio at ASH meet

Disc Medicine (IRON) spotlights 8 posters presented at the ASH 2024 annual meeting in San Diego, CA. This year’s presentations included updates from the BEACON and AURORA trials of bitopertin in ...